JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 351 KB, PDF-dokument
Originalsprog | Engelsk |
---|---|
Tidsskrift | Blood advances |
Vol/bind | 7 |
Udgave nummer | 19 |
Sider (fra-til) | 5825-5834 |
Antal sider | 10 |
ISSN | 2473-9529 |
DOI | |
Status | Udgivet - 2023 |
Bibliografisk note
Funding Information:
Grants were provided by the Greater Copenhagen Health Science Partners, Region Zealand Research Foundation, Toyota Foundation, Harboe Foundation, A.P. Moeller Foundation, Carpenter Sophus Jacobsen and Spouse Astrid Jacobsen Scholarship, Manufacturer Einar Willumsens Scholarship, Merchant A.V. Lykfeldt Scholarship, and the Department of Neurology, Zealand University Hospital, Denmark. GESUS was funded by the Region Zealand Research Foundation, Naestved Hospital Foundation, Naestved Municipality, Johan and Lise Boserup Foundation, Tryg-Fonden, Johannes Fog’s Foundation, Region Zealand, Naestved Hospital, The National Board of Health, and The Local Government
Funding Information:
Conflict-of-interest disclosure: H.C.H. has received a research grant from Novartis. The remaining authors declare no competing financial interest.
Publisher Copyright:
© 2023 American Society of Hematology. All rights reserved.
ID: 375055364